Oncology & Cancer

The dilemma of screening for prostate cancer

Primary care providers are put in a difficult position when screening their male patients for prostate cancer—some guidelines suggest that testing the general population lacks evidence whereas others state that it is appropriate ...

Oncology & Cancer

Metabolic compensation underlies drug resistance in glioblastoma

Gliobststoma (GBM) is a highly aggressive brain tumor that is resistant to many conventional cancer therapies. The kinase mTOR induces pathways that are aberrantly activated in GBM. However, mTOR inhibitors have not shown ...

page 10 from 20